Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): Price and Financial Metrics

ENZ POWR Grades

• ENZ scores best on the Sentiment dimension, with a Sentiment rank ahead of 77.31% of US stocks.
• ENZ's strongest trending metric is Growth; it's been moving down over the last 166 days.
• ENZ ranks lowest in Growth; there it ranks in the 7th percentile.

ENZ Stock Summary

• Enzo Biochem Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.84% of US equities in our set.
• With a price/earnings ratio of 483.84, Enzo Biochem Inc P/E ratio is greater than that of about 98.53% of stocks in our set with positive earnings.
• With a year-over-year growth in debt of -32.83%, Enzo Biochem Inc's debt growth rate surpasses only 12.52% of about US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to Enzo Biochem Inc are AVNS, ARTW, SAM, DOGZ, and ELMD.
• ENZ's SEC filings can be seen here. And to visit Enzo Biochem Inc's official web site, go to www.enzo.com.

ENZ Valuation Summary

• ENZ's price/earnings ratio is 138.4; this is 279.18% higher than that of the median Healthcare stock.
• Over the past 243 months, ENZ's price/sales ratio has gone down 11.5.
• ENZ's price/sales ratio has moved down 11.5 over the prior 243 months.

Below are key valuation metrics over time for ENZ.

ENZ Growth Metrics

Its 4 year cash and equivalents growth rate is now at 68.13%.
• Its 5 year net income to common stockholders growth rate is now at -273.83%.
• The 5 year price growth rate now stands at -58.11%.

ENZ's revenue has moved up $33,706,000 over the prior 15 months.

The table below shows ENZ's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	118.175	-4.258	0.3
2021-09-30	115.595	-4.448	5.257
2021-06-30	117.731	0.387	7.875
2021-03-31	112.445	-4.782	1.282
2020-12-31	96.551	-11.216	-10.584
2020-09-30	84.469	-16.321	-20.573

ENZ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ENZ has a Quality Grade of B, ranking ahead of 78.47% of graded US stocks.
• ENZ's asset turnover comes in at 1.04 -- ranking 20th of 81 Healthcare stocks.
• LFMD, RHE, and AHCO are the stocks whose asset turnover ratios are most correlated with ENZ.

The table below shows ENZ's key quality metrics over time.